Related Experiment Video
Updated: Mar 15, 2026

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells
Published on: April 25, 2018
Poly r(C) binding protein is post-transcriptionally repressed by MiR-490-3p to potentiate squamous cell carcinoma
Shan Xia1,2, Zigang Zhao1, Fang Xie1
1Department of Dermatology, Chinese PLA General Hospital, No. 28, Fuxing Road, Beijing, 100853, China.
Abstract:
Squamous cell skin carcinoma remains a leading cause of cancer-related mortality with a huge cost of treatment, necessitating discovery and validation of potent therapeutic targets. Poly r(C) binding protein 1 (PCBP1) has been previously shown to function as a tumor suppressor. Previous work has shown that PCBP1 expression is inversely correlated to maintenance of cancer stem cells in squamous cell skin carcinoma and prostate cancer, respectively. However, the precise mechanism that regulates PCBP1 expression has not been elucidated. Here, we show that loss of PCBP1 protein expression observed in CD34+ COLO-16 cells is orchestrated by translational silencing. Translational silencing is caused by targeting of PCBP1 mRNA by miR-490-3p. Exogenous manipulation of miR-490-3p levels can accordingly modulate PCBP1 protein expression, thus suggesting that miR-490-3p as a potential biomarker in squamous cell skin cancer with therapeutic benefits.
Insights
Researchers discovered that microRNA-490-3p silences the expression of Poly r(C) binding protein 1 (PCBP1) in squamous cell skin cancer. Modulating miR-490-3p offers a potential therapeutic strategy for this deadly cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Squamous cell skin carcinoma is a significant cause of cancer mortality.
- Poly r(C) binding protein 1 (PCBP1) acts as a tumor suppressor.
- PCBP1 expression is inversely correlated with cancer stem cell maintenance in certain cancers.
Purpose of the Study:
- To elucidate the regulatory mechanism of PCBP1 expression in squamous cell skin carcinoma.
- To investigate the role of microRNAs in PCBP1 regulation.
Main Methods:
- Analysis of PCBP1 protein expression in CD34+ COLO-16 cells.
- Identification of microRNA targeting PCBP1 mRNA.
- Exogenous manipulation of miR-490-3p levels.
Main Results:
- Loss of PCBP1 protein expression in CD34+ COLO-16 cells is due to translational silencing.
- PCBP1 mRNA is targeted by miR-490-3p, causing translational silencing.
- Modulating miR-490-3p levels affects PCBP1 protein expression.
Conclusions:
- miR-490-3p orchestrates the translational silencing of PCBP1 in squamous cell skin carcinoma.
- miR-490-3p represents a potential biomarker and therapeutic target for squamous cell skin cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
Co-activators and Co-repressors
Abnormal Proliferation
Transcriptional Regulation: Riboswitches
Regulation of Expression at Multiple Steps

